annual cash & cash equivalents:
$2.38B+$1.33B(+126.21%)Summary
- As of today (June 2, 2025), BIIB annual cash & cash equivalents is $2.38 billion, with the most recent change of +$1.33 billion (+126.21%) on December 31, 2024.
- During the last 3 years, BIIB annual cash & cash equivalents has risen by +$113.60 million (+5.02%).
- BIIB annual cash & cash equivalents is now -30.54% below its all-time high of $3.42 billion, reached on December 31, 2022.
Performance
BIIB Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.60B+$223.30M(+9.40%)Summary
- As of today (June 2, 2025), BIIB quarterly cash & cash equivalents is $2.60 billion, with the most recent change of +$223.30 million (+9.40%) on March 31, 2025.
- Over the past year, BIIB quarterly cash & cash equivalents has increased by +$1.52 billion (+141.84%).
- BIIB quarterly cash & cash equivalents is now -36.75% below its all-time high of $4.11 billion, reached on March 31, 2018.
Performance
BIIB quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BIIB Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +126.2% | +141.8% |
| 3 y3 years | +5.0% | +48.5% |
| 5 y5 years | -18.5% | +0.3% |
BIIB Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.5% | +126.2% | -29.3% | +147.5% |
| 5 y | 5-year | -30.5% | +126.2% | -29.3% | +147.5% |
| alltime | all time | -30.5% | >+9999.0% | -36.8% | >+9999.0% |
BIIB Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.60B(+9.4%) |
| Dec 2024 | $2.38B(+126.2%) | $2.38B(+39.8%) |
| Sep 2024 | - | $1.70B(-11.0%) |
| Jun 2024 | - | $1.91B(+77.7%) |
| Mar 2024 | - | $1.07B(+2.3%) |
| Dec 2023 | $1.05B(-69.3%) | $1.05B(-54.1%) |
| Sep 2023 | - | $2.29B(-12.6%) |
| Jun 2023 | - | $2.62B(-9.7%) |
| Mar 2023 | - | $2.90B(-15.2%) |
| Dec 2022 | $3.42B(+51.2%) | $3.42B(-7.0%) |
| Sep 2022 | - | $3.68B(+38.9%) |
| Jun 2022 | - | $2.65B(+51.3%) |
| Mar 2022 | - | $1.75B(-22.6%) |
| Dec 2021 | $2.26B(+69.9%) | $2.26B(+46.7%) |
| Sep 2021 | - | $1.54B(-11.5%) |
| Jun 2021 | - | $1.74B(+43.1%) |
| Mar 2021 | - | $1.22B(-8.5%) |
| Dec 2020 | $1.33B(-54.3%) | $1.33B(-40.2%) |
| Sep 2020 | - | $2.22B(-6.7%) |
| Jun 2020 | - | $2.38B(-8.0%) |
| Mar 2020 | - | $2.59B(-11.1%) |
| Dec 2019 | $2.91B(+137.9%) | $2.91B(+24.3%) |
| Sep 2019 | - | $2.34B(+36.0%) |
| Jun 2019 | - | $1.72B(-23.2%) |
| Mar 2019 | - | $2.24B(+83.2%) |
| Dec 2018 | $1.22B(-22.2%) | $1.22B(-48.7%) |
| Sep 2018 | - | $2.39B(+90.9%) |
| Jun 2018 | - | $1.25B(-69.6%) |
| Mar 2018 | - | $4.11B(+161.0%) |
| Dec 2017 | $1.57B(-32.4%) | $1.57B(+1.7%) |
| Sep 2017 | - | $1.55B(+32.4%) |
| Jun 2017 | - | $1.17B(+26.6%) |
| Mar 2017 | - | $924.00M(-60.3%) |
| Dec 2016 | $2.33B(+77.9%) | $2.33B(+11.6%) |
| Sep 2016 | - | $2.08B(+53.1%) |
| Jun 2016 | - | $1.36B(+20.5%) |
| Mar 2016 | - | $1.13B(-13.6%) |
| Dec 2015 | $1.31B(+8.6%) | $1.31B(-68.0%) |
| Sep 2015 | - | $4.09B(+218.9%) |
| Jun 2015 | - | $1.28B(-13.3%) |
| Mar 2015 | - | $1.48B(+22.7%) |
| Dec 2014 | $1.20B(+100.0%) | $1.20B(+1.6%) |
| Sep 2014 | - | $1.19B(+37.4%) |
| Jun 2014 | - | $863.20M(+4.2%) |
| Mar 2014 | - | $828.60M(+37.5%) |
| Dec 2013 | $602.56M(+5.6%) | $602.56M(+40.8%) |
| Sep 2013 | - | $427.81M(+9.0%) |
| Jun 2013 | - | $392.51M(-40.8%) |
| Mar 2013 | - | $663.30M(+16.2%) |
| Dec 2012 | $570.72M(+10.9%) | $570.72M(+26.3%) |
| Sep 2012 | - | $451.72M(-1.1%) |
| Jun 2012 | - | $456.81M(+53.2%) |
| Mar 2012 | - | $298.14M(-42.1%) |
| Dec 2011 | $514.54M(-32.3%) | $514.54M(-10.5%) |
| Sep 2011 | - | $575.14M(-17.5%) |
| Jun 2011 | - | $697.53M(-11.8%) |
| Mar 2011 | - | $790.67M(+4.1%) |
| Dec 2010 | $759.60M(+30.5%) | $759.60M(+21.2%) |
| Sep 2010 | - | $626.76M(-13.1%) |
| Jun 2010 | - | $720.96M(+12.7%) |
| Mar 2010 | - | $639.56M(+9.9%) |
| Dec 2009 | $581.89M(-6.5%) | $581.89M(-0.7%) |
| Sep 2009 | - | $585.79M(-25.5%) |
| Jun 2009 | - | $786.80M(+3.0%) |
| Mar 2009 | - | $764.10M(+22.8%) |
| Dec 2008 | $622.38M(-5.7%) | $622.38M(-38.4%) |
| Sep 2008 | - | $1.01B(+116.7%) |
| Jun 2008 | - | $466.49M(-32.2%) |
| Mar 2008 | - | $688.50M(+4.4%) |
| Dec 2007 | $659.66M(-0.3%) | $659.66M(+50.8%) |
| Sep 2007 | - | $437.33M(-72.9%) |
| Jun 2007 | - | $1.61B(+106.4%) |
| Mar 2007 | - | $780.94M(+18.1%) |
| Dec 2006 | $661.38M | $661.38M(+59.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $414.59M(+20.1%) |
| Jun 2006 | - | $345.10M(-35.6%) |
| Mar 2006 | - | $535.87M(-5.7%) |
| Dec 2005 | $568.17M(+171.3%) | $568.17M(+91.6%) |
| Sep 2005 | - | $296.49M(-53.6%) |
| Jun 2005 | - | $638.40M(+130.9%) |
| Mar 2005 | - | $276.44M(+32.0%) |
| Dec 2004 | $209.45M(-33.5%) | $209.45M(+17.0%) |
| Sep 2004 | - | $179.02M(-63.0%) |
| Jun 2004 | - | $483.31M(+59.6%) |
| Mar 2004 | - | $302.79M(-3.8%) |
| Dec 2003 | $314.85M(-10.1%) | $314.85M(+175.3%) |
| Sep 2003 | - | $114.36M(+84.0%) |
| Jun 2003 | - | $62.15M(+71.4%) |
| Mar 2003 | - | $36.26M(-89.6%) |
| Dec 2002 | $350.13M(+547.9%) | $350.13M(+593.2%) |
| Sep 2002 | - | $50.51M(+67.0%) |
| Jun 2002 | - | $30.23M(-68.0%) |
| Mar 2002 | - | $94.52M(+74.9%) |
| Dec 2001 | $54.04M(+10.9%) | $54.04M(-9.3%) |
| Sep 2001 | - | $59.61M(-21.5%) |
| Jun 2001 | - | $75.97M(+167.0%) |
| Mar 2001 | - | $28.45M(-41.6%) |
| Dec 2000 | $48.74M(-14.4%) | $48.74M(+36.0%) |
| Sep 2000 | - | $35.85M(-46.9%) |
| Jun 2000 | - | $67.46M(-33.9%) |
| Mar 2000 | - | $102.04M(+79.3%) |
| Dec 1999 | $56.92M(+123.7%) | $56.92M(-22.6%) |
| Sep 1999 | - | $73.50M(+39.5%) |
| Jun 1999 | - | $52.70M(-42.3%) |
| Mar 1999 | - | $91.40M(+259.2%) |
| Dec 1998 | $25.45M(-63.8%) | $25.45M(-73.0%) |
| Sep 1998 | - | $94.20M(+31.2%) |
| Jun 1998 | - | $71.80M(+9.5%) |
| Mar 1998 | - | $65.60M(-6.8%) |
| Dec 1997 | $70.36M(+13.4%) | $70.36M(+12.4%) |
| Sep 1997 | - | $62.60M(-14.6%) |
| Jun 1997 | - | $73.30M(-27.8%) |
| Mar 1997 | - | $101.50M(+63.6%) |
| Dec 1996 | $62.03M(+35.5%) | $62.03M(-0.9%) |
| Sep 1996 | - | $62.60M(+25.0%) |
| Jun 1996 | - | $50.10M(+54.2%) |
| Mar 1996 | - | $32.50M(-29.0%) |
| Dec 1995 | $45.77M(-16.3%) | $45.77M(-12.8%) |
| Sep 1995 | - | $52.50M(+12.4%) |
| Jun 1995 | - | $46.70M(-31.7%) |
| Mar 1995 | - | $68.40M(+25.1%) |
| Dec 1994 | $54.68M(-26.6%) | $54.68M(-16.5%) |
| Sep 1994 | - | $65.50M(+67.5%) |
| Jun 1994 | - | $39.10M(-25.8%) |
| Mar 1994 | - | $52.70M(-29.3%) |
| Dec 1993 | $74.50M(-13.3%) | $74.50M(-0.5%) |
| Sep 1993 | - | $74.90M(-3.0%) |
| Jun 1993 | - | $77.20M(+62.9%) |
| Mar 1993 | - | $47.40M(-44.8%) |
| Dec 1992 | $85.90M(+51.8%) | $85.90M(+13.9%) |
| Sep 1992 | - | $75.40M(+104.9%) |
| Jun 1992 | - | $36.80M(-5.2%) |
| Mar 1992 | - | $38.80M(-31.4%) |
| Dec 1991 | $56.60M(+349.2%) | $56.60M(+177.5%) |
| Sep 1991 | - | $20.40M(+482.9%) |
| Jun 1991 | - | $3.50M(-79.5%) |
| Mar 1991 | - | $17.10M(+35.7%) |
| Dec 1990 | $12.60M(-62.0%) | $12.60M(-13.1%) |
| Sep 1990 | - | $14.50M(-15.7%) |
| Jun 1990 | - | $17.20M(+20.3%) |
| Mar 1990 | - | $14.30M(-56.9%) |
| Dec 1989 | $33.20M(-38.9%) | $33.20M(+2.8%) |
| Sep 1989 | - | $32.30M(-40.5%) |
| Dec 1988 | $54.30M(-0.2%) | $54.30M(-0.2%) |
| Dec 1987 | $54.40M(-22.8%) | $54.40M(-22.8%) |
| Dec 1986 | $70.50M(+31.8%) | $70.50M(+31.8%) |
| Dec 1985 | $53.50M(-28.6%) | $53.50M(-28.6%) |
| Dec 1984 | $74.90M | $74.90M |
FAQ
- What is Biogen annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Biogen?
- What is Biogen annual cash & cash equivalents year-on-year change?
- What is Biogen quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Biogen?
- What is Biogen quarterly cash & cash equivalents year-on-year change?
What is Biogen annual cash & cash equivalents?
The current annual cash & cash equivalents of BIIB is $2.38B
What is the all time high annual cash & cash equivalents for Biogen?
Biogen all-time high annual cash & cash equivalents is $3.42B
What is Biogen annual cash & cash equivalents year-on-year change?
Over the past year, BIIB annual cash & cash equivalents has changed by +$1.33B (+126.21%)
What is Biogen quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BIIB is $2.60B
What is the all time high quarterly cash & cash equivalents for Biogen?
Biogen all-time high quarterly cash & cash equivalents is $4.11B
What is Biogen quarterly cash & cash equivalents year-on-year change?
Over the past year, BIIB quarterly cash & cash equivalents has changed by +$1.52B (+141.84%)